← Back to Search

Procedure

Cordotomy for Cancer Pain Management

N/A
Recruiting
Led By Eduardo Bruera
Research Sponsored by M.D. Anderson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Unilateral pain due to cancer below the shoulder level (arm, trunk, hip, leg)
Has undergone 3 palliative care evaluations
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 6 months
Awards & highlights

Study Summary

This trial is studying how well cordotomy works in reducing pain for patients with advanced cancer. Cordotomy is a procedure where a needle is used to target the spinal cord, guided by CT scans. The study is being done to see if cordotomy can help reduce pain for patients with cancer who can't manage their pain.

Who is the study for?
This trial is for advanced cancer patients with pain intensity of 4 or higher on a scale of 0-10, specifically below the shoulder level. Participants must have had three palliative care evaluations and be able to consent. Those who can't complete forms, have less than a month to live, issues with blood clotting, sedation risks, brain tumors or morphine allergies cannot join.Check my eligibility
What is being tested?
The study tests if cordotomy—a needle procedure on the spinal cord guided by CT scans—can reduce severe cancer-related pain better than standard treatments like morphine. Patients will also answer questionnaires about their pain levels.See study design
What are the potential side effects?
Cordotomy may cause discomfort at the injection site, potential nerve damage leading to weakness or numbness, and risks associated with sedation. Morphine's side effects include drowsiness, constipation, nausea and potential dependency.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have cancer-related pain in one side of my body below the shoulder.
Select...
I have had three evaluations for symptom management and support.
Select...
My pain level is 4 or higher on a scale of 0 to 10.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Reduction in pain intensity
Secondary outcome measures
Brief Pain Inventory pain interference items
Other ESAS symptoms

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Group I (cordotomy)Experimental Treatment2 Interventions
Patients undergo a cordotomy over 1-2 hours.
Group II: Group II (morphine, fake cordotomy)Placebo Group3 Interventions
Patients receive morphine via injection into the spine and undergo a fake cordotomy over 1-2 hours.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cordotomy
2015
N/A
~20

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Cordotomy is a surgical procedure that interrupts pain pathways in the spinal cord, providing relief for cancer patients with severe, refractory pain. This is particularly important for those with advanced cancer, as it can significantly improve their quality of life. Other treatments, such as radiation therapy, work by shrinking tumors that cause pain through pressure on nerves or bones. Pharmacologic approaches, including opioids and adjuvant analgesics, modulate pain perception at different points in the nervous system. Understanding these mechanisms allows for personalized pain management strategies, enhancing patient comfort and daily functioning.
Surgical cordotomy helps psychosocial suffering.Minimally Invasive Cordotomy for Refractory Cancer Pain: A Randomized Controlled Trial.

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,719 Previous Clinical Trials
40,963,516 Total Patients Enrolled
M.D. Anderson Cancer CenterLead Sponsor
2,992 Previous Clinical Trials
1,792,613 Total Patients Enrolled
National Institute of Nursing Research (NINR)NIH
585 Previous Clinical Trials
10,379,272 Total Patients Enrolled

Media Library

Cordotomy (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT04119037 — N/A
Cancer Research Study Groups: Group II (morphine, fake cordotomy), Group I (cordotomy)
Cancer Clinical Trial 2023: Cordotomy Highlights & Side Effects. Trial Name: NCT04119037 — N/A
Cordotomy (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04119037 — N/A
~8 spots leftby Sep 2025